Surveying how doctors refer people with suspected chronic lymphocytic leukaemia to specialists
Surveys doctors about how they refer chronic lymphocytic leukaemia cases in the West Midlands.
Key facts
- Who runs it
- The Royal Wolverhampton Hospitals NHS Trust
- Where
- Wolverhampton, United KingdomSee the site
- Trial code
- Registry title
- variaTIon in Referral Thresholds in the Chronic Lymphocytic LeukaEmia Pathway
- Status
- Not yet recruiting
- People taking part
- 130 people, planned
- Starts
- Dec 2026
- Expected to end
- Jul 2027
- Type of study
- Observational
- Record updated
- 15 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The study is looking for primary care providers and clinical nurse specialists in the West Midlands to answer surveys about how they refer people with CLL.
- Sex
- Everyone can join, regardless of sex.
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Primary Care Provider
- Clinical Nurse Specialist
Who cannot take part
- -
Where in United Kingdom
- The Royal Wolverhampton NHS TrustWolverhampton, United KingdomContact: Shankara PaneeshaNo longer taking part
About the trial
What the trial wants to find out
This study will use surveys within primary and secondary care to explore referral patterns and healthcare professional (HCP) decision-making and advice for haematological malignancies, identify inequalities, and establish best practice for CLL referrals and specialist support. The project will allow us to understand and 'map' variations in practice across the West Midlands region with regard to referrals for CLL from primary care physicians to haematology services in secondary care.
Read full original descriptionShow less
Specific objectives are to:
1. Identify service variations by using surveys to assess differences in CLL service provision across primary and secondary care in the West Midlands 2. Investigate service variations by describing the key characteristics of responding primary care practices (practice size, number of GPs, Integrated Care Board (ICB) locality, deprivation quartile) 3. Propose strategies to improve equity that will enhanced patient outcomes and reduce inequalities in care for CLL patients, aiming to ensure consistent standards for referral and management across different care settings.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- variaTIon in Referral Thresholds in the Chronic Lymphocytic LeukaEmia Pathway (TITLE CLL)
- Plain-language title
- Surveying how doctors refer people with suspected chronic lymphocytic leukaemia to specialistsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 15 September 2026